NextCell Pharma (Sweden) Price on March 6, 2023
| NXTCL Stock | SEK 1.75 0.02 1.13% |
If you're considering investing in NextCell Stock, it is important to understand the factors that can impact its price. As of today, the current price of NextCell Pharma stands at 1.75, as last reported on the 30th of November, with the highest price reaching 1.82 and the lowest price hitting 1.70 during the day. NextCell Pharma appears to be very risky, given 3 months investment horizon. NextCell Pharma AB has Sharpe Ratio of 0.14, which conveys that the firm had a 0.14% return per unit of risk over the last 3 months. By analyzing NextCell Pharma's technical indicators, you can evaluate if the expected return of 0.55% is justified by implied risk. Please exercise NextCell Pharma's Downside Deviation of 3.13, risk adjusted performance of 0.1161, and Mean Deviation of 2.83 to check out if our risk estimates are consistent with your expectations.
NextCell Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
NextCell |
Sharpe Ratio = 0.1383
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | NXTCL | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.98 actual daily | 35 65% of assets are more volatile |
Expected Return
| 0.55 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
| 0.14 actual daily | 10 90% of assets perform better |
Based on monthly moving average NextCell Pharma is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NextCell Pharma by adding it to a well-diversified portfolio.
NextCell Pharma Valuation on March 6, 2023
It is possible to determine the worth of NextCell Pharma on a given historical date. On March 6, 2023 NextCell was worth 6.75 at the beginning of the trading date compared to the closed value of 6.68. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of NextCell Pharma stock. Still, in general, we apply an absolute valuation method to find NextCell Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of NextCell Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against NextCell Pharma's related companies.
| Open | High | Low | Close | Volume | |
| 7.05 | 7.05 | 6.71 | 6.86 | 8,066 | |
03/06/2023 | 6.75 | 6.81 | 6.53 | 6.68 | 14,243 |
| 6.87 | 6.87 | 6.27 | 6.40 | 22,067 |
| Backtest NextCell Pharma | | | NextCell Pharma History | | | NextCell Pharma Valuation | Previous | Next |
NextCell Pharma Trading Date Momentum on March 6, 2023
| On March 07 2023 NextCell Pharma AB was traded for 6.40 at the closing time. The highest price during the trading period was 6.87 and the lowest recorded bid was listed for 6.27 . The volume for the day was 22.1 K. This history from March 7, 2023 contributed to the next trading day price decline. The trading delta at closing time to the next closing price was 4.19% . The trading delta at closing time to the current price is 7.78% . |
NextCell Pharma AB Fundamentals Correlations and Trends
By evaluating NextCell Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among NextCell Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. NextCell financial account trend analysis is a perfect complement when working with valuation or volatility modules.About NextCell Pharma Stock history
NextCell Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for NextCell is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in NextCell Pharma AB will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing NextCell Pharma stock prices may prove useful in developing a viable investing in NextCell Pharma
NextCell Pharma AB operates as a tissue establishment and primary biobank in Sweden. NextCell Pharma AB was founded in 2014 and is based in Huddinge, Sweden. NextCell Pharma operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 10 people.
NextCell Pharma Stock Technical Analysis
NextCell Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
NextCell Pharma Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
NextCell Pharma AB cannot be verified against its exchange. Please verify the symbol is currently traded on Stockholm Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
NextCell Pharma November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how NextCell Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NextCell Pharma shares will generate the highest return on investment. By undertsting and applying NextCell Pharma stock market strength indicators, traders can identify NextCell Pharma AB entry and exit signals to maximize returns
NextCell Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for NextCell Pharma's price direction in advance. Along with the technical and fundamental analysis of NextCell Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of NextCell to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1161 | |||
| Jensen Alpha | 0.5003 | |||
| Total Risk Alpha | (0.11) | |||
| Sortino Ratio | 0.1358 | |||
| Treynor Ratio | 1.36 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for NextCell Stock Analysis
When running NextCell Pharma's price analysis, check to measure NextCell Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NextCell Pharma is operating at the current time. Most of NextCell Pharma's value examination focuses on studying past and present price action to predict the probability of NextCell Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NextCell Pharma's price. Additionally, you may evaluate how the addition of NextCell Pharma to your portfolios can decrease your overall portfolio volatility.